Tusk Therapeutics Ltd.
https://www.roche.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Tusk Therapeutics Ltd.
Still Looking For A Cancer Vaccine Breakthrough, Roche Signs $200m Vaccibody Deal
Despite a recent disappointment in a similar partnership with BioNTech, Genentech is pushing ahead with its neoantigen-targeting strategy.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule